Improving the outcome of adoptive cell transfer by targeting tumor escape

 Abstract

Adoptive T-cell transfer is among the most promising immunotherapies against cancer. To continue increasing the potential of this therapy, our studies focus on the inhibition of tumor recurrence. Recently, we have demonstrated several ways in which combination therapies involving multiple T-cell populations and immunostimulatory chemotherapy can enhance long-term survival.

Full Text Options
Article
Metrics
 Share
 Full Text
 Info
eLocation ID
e22059
doi
10.4161/onci.22059
Type
Author's View
 Metrics
 Cite This Article
 Permissions
Creative Commons License Permissions
 Reprints
Improving the outcome of adoptive cell transfer by targeting tumor escape